FDA-approved drugs as PIM-1 kinase inhibitors: A drug repurposed approach for cancer therapy

Autor: Rathi, Aanchal a, Noor, Saba b, Sulaimani, Md Nayab b, Ahmed, Shahbaz b, Taiyab, Aaliya b, AlAjmi, Mohamed F. c, Khan, Faez Iqbal d, Hassan, Md. Imtaiyaz b, ⁎, Haque, Mohammad Mahfuzul a, ⁎⁎
Zdroj: In International Journal of Biological Macromolecules March 2025 292
Databáze: ScienceDirect